Form 4 for ADCT ADC Therapeutics SA
Accepted 2025-06-05 00:00:00 ET · period of report 2025-06-03 · accession 0001628280-25-029742 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-06-05 | 2025-06-03 | ADCT | COUGHLIN TIMOTHY | Dir | A - Grant | $0.00 | +40.0K | 40.0K | New | $0 |
| D | 2025-06-05 | 2025-06-03 | ADCT | COUGHLIN TIMOTHY | Dir | A - Grant | $0.00 | +80.0K | 80.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2025-06-03 | A | A | 40,000 | $0.00 | 40,000 | D | — | — | (F1) Represents the annual grant of restricted stock units ("RSUs") made under the Issuer's 2019 Equity Incentive Plan for service as a Director. The RSUs vest one year from the grant date, subject to the Reporting Person's continued service to the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock. |
| 2 | Derivative | Stock Options (Right to Buy) | 2025-06-03 | A | A | 80,000 | $0.00 | 80,000 | D | $3.59 · — to 2035-06-05 | 80,000 Common Shares | (F2) Represents a one-time initial stock option award made under the Issuer's 2019 Equity Incentive Plan. The options vest over four years from June 3, 2025, with 1/4 vesting on the first anniversary of such date, and the remainder vesting monthly in 36 equal installments, subject to continued service through each such vesting date. |